Literature DB >> 12629567

A novel nonsense mutation in the melanocortin-4 receptor associated with obesity in a Spanish population.

A Marti1, M S Corbalán, L Forga, J A Martinez, A Hinney, J Hebebrand.   

Abstract

BACKGROUND: In recent years, several groups have reported dominant inheritance of obesity conferred by missense, nonsense and frameshift mutations in the melanocortin 4 receptor gene (MC4R). Hence, MC4R is involved in the most common monogenic form of human obesity described so far.
OBJECTIVES: In this context, we screened a Spanish population, composed of obese subjects and normal weight controls, for mutations in the MC4-R by single-strand conformational polymorphism (SSCP). SUBJECTS AND METHODS: Overall 313 individuals, 159 obese subjects (body mass index: BMI: 37.6 kg/m(2), 95% CI: 36.7-38.5 kg/m(2)) and 154 normal weight control subjects (BMI: 22.3 kg/m(2), 95% CI: 22.0-22.6 kg/m(2)) were screened for MC4-R mutations.
RESULTS: We detected a novel nonsense mutation at codon 16 of the MC4-R in an obese female (BMI: 30.0 kg/m(2)) and a previously described missense mutation (Val-253-Ile) located within the sixth trans-membrane domain of the MC4-R in a normal weight individual (BMI: 19.0 kg/m(2)). The polymorphism Val-103-Ile was detected in one obese individual, while four subjects (two cases and two controls) with the polymorphism Ile-251-Leu were found.
CONCLUSIONS: We have identified a novel nonsense mutation (Trp-16-Stop) that, based on previously described frameshift and nonsense mutations, most likely results in dominantly inherited obesity. Within this Spanish population, the frequency of the Ile-251-Leu polymorphism of the MC4R was similar in obese and control subjects (about 1.3%), while the polymorphism Val-103-Ile was only detected in an obese individual (0.6%).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629567     DOI: 10.1038/sj.ijo.0802244

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  9 in total

Review 1.  Mouse models of the metabolic syndrome.

Authors:  Arion J Kennedy; Kate L J Ellacott; Victoria L King; Alyssa H Hasty
Journal:  Dis Model Mech       Date:  2010 Mar-Apr       Impact factor: 5.758

2.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

3.  Melanocortin-4 receptor gene variant I103 is negatively associated with obesity.

Authors:  Frank Geller; Kathrin Reichwald; Astrid Dempfle; Thomas Illig; Caren Vollmert; Stephan Herpertz; Winfried Siffert; Matthias Platzer; Claudia Hess; Thomas Gudermann; Heike Biebermann; H-Erich Wichmann; Helmut Schäfer; Anke Hinney; Johannes Hebebrand
Journal:  Am J Hum Genet       Date:  2004-02-17       Impact factor: 11.025

4.  Polymorphism Val103Ile of the melanocortin-4 receptor gene in the Serbian population.

Authors:  E Stokić; M Djan; Lj Vapa; I Djan; A Plećas; B Srdić
Journal:  Mol Biol Rep       Date:  2009-03-13       Impact factor: 2.316

5.  Obesity and eating behaviour in a three-generation Chilean family with carriers of the Thrl50Ile mutation in the melanocortin-4 receptor gene.

Authors:  J L Santos; P Amador; M Valladares; C Albala; J A Martínez; A Marti
Journal:  J Physiol Biochem       Date:  2008-09       Impact factor: 4.158

Review 6.  Approach to assessing determinants of glucose homeostasis in the conscious mouse.

Authors:  Curtis C Hughey; David H Wasserman; Robert S Lee-Young; Louise Lantier
Journal:  Mamm Genome       Date:  2014-07-30       Impact factor: 2.957

7.  The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29 563 individuals.

Authors:  E H Young; N J Wareham; S Farooqi; A Hinney; J Hebebrand; A Scherag; S O'rahilly; I Barroso; M S Sandhu
Journal:  Int J Obes (Lond)       Date:  2007-03-13       Impact factor: 5.095

8.  Implication of Melanocortin Receptor Genes in the Familial Comorbidity of Type 2 Diabetes and Depression.

Authors:  Mutaz Amin; Jurg Ott; Rongling Wu; Teodor T Postolache; Claudia Gragnoli
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

9.  Design and evaluation of a treatment programme for Spanish adolescents with overweight and obesity. The EVASYON Study.

Authors:  David Martinez-Gomez; Sonia Gomez-Martinez; M Angeles Puertollano; Esther Nova; Julia Wärnberg; Oscar L Veiga; Amelia Martí; Cristina Campoy; Jesus M Garagorri; Cristina Azcona; M Pilar Vaquero; Carlos Redondo-Figuero; Manuel Delgado; J Alfredo Martínez; Miguel Garcia-Fuentes; Luis A Moreno; Ascension Marcos
Journal:  BMC Public Health       Date:  2009-11-15       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.